cdmo.directory
← Compare landing

Clearsynth vs Dipharma

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/clearsynth/dipharma

CategoryClearsynthDipharma
Listed sitecdmocdmo
SummaryClearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.
Services
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Quality Control Testing
  • API Synthesis & Manufacturing
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Quality Control Testing
Modalities
  • Small Molecule
  • Small Molecule
IndicationsData not yet provided.Data not yet provided.
Locations
  • Corporate Headquarters, Mumbai, Maharashtra, India
  • Regional Office, Canada, Canada
  • Regional Office, USA, United States
  • Headquarters, Milan, Lombardy, Italy
  • Commercial Office, United States
  • Commercial Office, China
Certifications
  • ISO · Identifier: ISO 17025
  • ISO · Identifier: ISO 17034
  • ISO · Identifier: ISO 9001:2015
  • DSIR · Identifier: DSIR Recognized
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.